packageAnecortave

anecortave

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Anecortave is an angiogenesis inhibitor studied as an eye medicine for ocular vascular disorders involving abnormal new blood vessel growth. It remains experimental and is not an approved treatment.

Summary written by glm-5.3-flash from Wikidata Q27287834 and the WHO ATC classification; not checked by a person.

name:anecortave
ATC codes:S01LA02
DrugBank:DB12081
PubChem CID:7074810
ChEBI:177649
Wikidata:Q27287834
formula:C21H28O4
molar mass:344.451 g/mol (PubChem CID 7074810)
logP:2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown